Keyphrases
Alcohol Use Disorder
77%
Advanced Fibrosis
66%
Alcohol Use Disorder Treatment
48%
Fibrosis-4 (FIB-4)
44%
Alcoholic Liver Disease
42%
Impaired Fasting Glucose
33%
Vitamin D Deficiency
33%
Innovative Approach
33%
Call to Action
33%
Clinical Features
33%
Laboratory Values
33%
Yale
22%
Liver Disease
15%
Alcohol Consumption
15%
Binge Drinking
14%
New Haven
11%
25-hydroxyvitamin D (25OHD)
11%
Fasting Plasma Glucose
11%
Trias
11%
Pharmacological Treatment
11%
Spain
11%
Europe
11%
Liver
11%
Connecticut
11%
United States
11%
Treatment Choice
11%
Innovative Therapies
11%
United States of America
11%
Liver Transplantation
11%
Liver Cirrhosis
11%
Unhealthy Alcohol Use
11%
Treatment Strategy
11%
Post-Study System Usability Questionnaire
11%
Substance Use
10%
Sociodemographic Data
10%
Use Characteristics
10%
Anemia
9%
Standard Drink
9%
Leukopenia
9%
Metabolic Complications
5%
Prevalence of Vitamin D Deficiency
5%
Insulin Resistance
5%
Risk Factors
5%
β-cell Dysfunction
5%
Chemiluminescent Enzyme Immunoassay (CLEIA)
5%
Serum Concentration
5%
Vitamin D Status
5%
Type 2 Diabetes Mellitus (T2DM)
5%
25(OH)D Level
5%
Comorbidity
5%
Medicine and Dentistry
Alcoholic Polyneuropathy
100%
Liver Fibrosis
66%
Liver Disease
58%
Impaired Fasting Glucose
33%
Vitamin D Deficiency
33%
Clinical Feature
33%
Fibrosis
33%
Hypovitaminosis D
33%
Alcohol Consumption
30%
Prevalence
15%
Binge Drinking
14%
Drug Therapy
11%
Experimental Therapy
11%
Liver Transplantation
11%
Medicine
11%
Blood Glucose
11%
Liver Cirrhosis
11%
Focused Ion Beam
11%
Vitamin D
11%
Leukopenia
9%
Anemia
9%
Bilirubin
9%
Body Mass Index
5%
Immunoassay Method
5%
Beta Cell
5%
Maturity Onset Diabetes of the Young
5%
25 Hydroxyvitamin D
5%
Platelet
5%
Insulin Resistance
5%
Cross Sectional Study
5%
Comorbidity
5%
Biochemistry, Genetics and Molecular Biology
Prevalence
44%
Bilirubin
33%
Hypovitaminosis D
33%
Multivariate Analysis
33%
Bilirubin Blood Level
33%
CD4
33%
T Cell
33%
Memory B Cell
22%
Glucose Blood Level
11%
Vitamin D
11%
Cell Loss
11%
Focused Ion Beam
11%
Cross Sectional Study
5%
Blood Level
5%
Platelet
5%
Insulin Resistance
5%
Comorbidity
5%
Immunoassay
5%
